[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @jlucer53 John Lucero, Pmhnp John Lucero, Pmhnp posts on X about $sprb, $amrn, generational, loaded the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::877571654179844098/interactions)  - X Week XXXXX +475% - X Month XXXXX -XX% - X Months XXXXXX +511% - X Year XXXXXX +341% ### Mentions: XX [#](/creator/twitter::877571654179844098/posts_active)  - X Months XX +491% - X Year XX +756% ### Followers: XXX [#](/creator/twitter::877571654179844098/followers)  - X Week XXX +7.10% - X Month XXX +12% - X Months XXX +69% - X Year XXX +123% ### CreatorRank: undefined [#](/creator/twitter::877571654179844098/influencer_rank)  ### Social Influence **Social topic influence** [$sprb](/topic/$sprb) #10, [$amrn](/topic/$amrn), [generational](/topic/generational), [loaded](/topic/loaded), [has been](/topic/has-been), [at least](/topic/at-least), [if you](/topic/if-you), [ultra](/topic/ultra) **Top accounts mentioned or mentioned by** [@grok](/creator/undefined) [@martinshkreli](/creator/undefined) [@monacobiotech](/creator/undefined) [@thothcapital](/creator/undefined) [@anthonystaj](/creator/undefined) [@seedy19tron](/creator/undefined) [@commonsenseplay](/creator/undefined) [@elonmusk](/creator/undefined) [@bryanjohnson](/creator/undefined) [@jfais20](/creator/undefined) [@ryansttrader](/creator/undefined) [@adrianhorning](/creator/undefined) [@andreagtc](/creator/undefined) [@pharmdca](/creator/undefined) [@jasona](/creator/undefined) [@emuconspiracy](/creator/undefined) [@logicalthesis](/creator/undefined) [@hackertrader](/creator/undefined) [@brainymarsupial](/creator/undefined) [@tatethetalisman](/creator/undefined) ### Top Social Posts Top posts by engagements in the last XX hours "@drsprs @SSampson60391 $sprb and $amrn to break even In 12-18 months depending on position size. Only a psych NP but I've done as much DD as a generalist can do. I can't find another risk reward ratio (specifically spruce) to get even on" [X Link](https://x.com/jlucer53/status/1996370338788291070) 2025-12-04T00:05Z XXX followers, XXX engagements "@ThothCapital Iucky. I held like an idiot. Would have loaded the boat at under XX. Fundamentals are still intact and I don't see why FDA would not fast track this. Data is clear and not questionable. Generational miss on my part $SPRB" [X Link](https://x.com/jlucer53/status/1995608795347890668) 2025-12-01T21:39Z XXX followers, XXX engagements "@MartinShkreli are you going to hold through or cover hoping $sprb makes this back. hoping you can shed more light on that over time. ive done my own DD and heard yours but any more insight is always helpful" [X Link](https://x.com/jlucer53/status/1996245629907898712) 2025-12-03T15:50Z XXX followers, 8260 engagements "@BayStreetBull @anthonystaj $sprb it is" [X Link](https://x.com/jlucer53/status/1996367249926738173) 2025-12-03T23:53Z XXX followers, XX engagements "@anthonystaj $sprb it is" [X Link](https://x.com/jlucer53/status/1996367302741385324) 2025-12-03T23:53Z XXX followers, XXX engagements "@AgonInvestments @anthonystaj $sprb it is" [X Link](https://x.com/jlucer53/status/1996367430323732541) 2025-12-03T23:54Z XXX followers, XX engagements "@jeremyj0916 @Biotenic Same. $sprb and $amrn (way more weight on spruce) are the only relatively safe plays I know of to go heavier in order to break even or if you're savage turn a profit dependent on your position size" [X Link](https://x.com/jlucer53/status/1996369448484409525) 2025-12-04T00:02Z XXX followers, XX engagements "@FSUspencer @jeremyj0916 @MartinShkreli Take the extra cash and get into $sprb or imo $amrn. Going to take 12-18 months but better risk reward. Avxl crowd is interesting. I think they keep buying until they can't" [X Link](https://x.com/jlucer53/status/1996373790247493744) 2025-12-04T00:19Z XXX followers, XXX engagements "@houndcl @davidmiedz I never ever short for this reason but I felt compelled and got absolutely smoked. RR is hardly ever there but the pathology/biology made no sense. Still think something is funny but $sprb & $amrn for the win in 12-18 months. Long and gone" [X Link](https://x.com/jlucer53/status/1996383458776777207) 2025-12-04T00:58Z XXX followers, XXX engagements "@commonsenseplay @ShashiVas Why do you think $sprb has higher risk The data is irrefutable (to my understanding) and ICV method has been proven once in the real world already. FDA agreed to the biomarker and it was reduced. Study over X years. Genuine question. Thoughts" [X Link](https://x.com/jlucer53/status/1996599828927635789) 2025-12-04T15:17Z XXX followers, XXX engagements "@Relic57647069 @commonsenseplay My thoughts exactly. $sprb im trying to find downsides and I can't. FDA agreed to the biomarker and it was reduced dramatically. No one is arguing the data. Icv is used today. Regulatory risk which I don't see why on this one shouldn't be an issue" [X Link](https://x.com/jlucer53/status/1996600330125975940) 2025-12-04T15:19Z XXX followers, XXX engagements "@Anders_Research @idalopirdine @MartinShkreli $sprb to make it back. Why wouldn't FDA approve on phase X I can't find any bear thesis or information to prove otherwise. This looks like a lock" [X Link](https://x.com/jlucer53/status/1996676213562351952) 2025-12-04T20:21Z XXX followers, XXX engagements "@jacobg0121 XXX% correct.6070 % of CRLs for gene therapies and enzyme replacement therapies contain at least one CMC item. This is under LIC from biomarin. They have already executed this model so $sprb will just copy that.March package included CMC. Btd allows for rolling reviews. Low risk" [X Link](https://x.com/jlucer53/status/1996804617385189377) 2025-12-05T04:51Z XXX followers, XXX engagements "@Ricardomatepin @BrainyMarsupial I've done heavy DD on the data (my strength) and I don't see a reason why this wouldn't be acceptable in this context. Thoughts Also thanks for this back and forth CMC is my weak point so I appreciate the conversation here $sprb" [X Link](https://x.com/jlucer53/status/1996807224275153189) 2025-12-05T05:01Z XXX followers, XXX engagements "@seedy19tron I implore you to deep dive on $sprb esp at these levels. Open to chat if you would like" [X Link](https://x.com/jlucer53/status/1997053831415582813) 2025-12-05T21:21Z XXX followers, XXX engagements "@BrainyMarsupial @EmuConspiracy @Andre_AGTC Yeah in ultra rare the number shoots into the 80s. Fdas agreeance to take HS as a marker plus cortical endpoints at p0.0001 are irrefutable. They even met the more subjective endpoints hence the BTD. Real risk is CMC. We need to talk to a manf expert with exp in enzymes" [X Link](https://x.com/jlucer53/status/1997322029977022674) 2025-12-06T15:07Z XXX followers, XX engagements "@LogicalThesis @marketplunger1 $sprb triples" [X Link](https://x.com/jlucer53/status/1997326700217037122) 2025-12-06T15:26Z XXX followers, XXX engagements "@willkyi @drsprs Sizing is everything I way over sized this. Everyone needs to check out $sprb to make it back. RR is on our side this time on the long side" [X Link](https://x.com/jlucer53/status/1997435108106948891) 2025-12-06T22:36Z XXX followers, XXX engagements "@Respekchemistry @johnkmason @grok what's the price of chiesi's new ERT drug" [X Link](https://x.com/jlucer53/status/1997750769668571386) 2025-12-07T19:31Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@jlucer53 John Lucero, Pmhnp
John Lucero, Pmhnp posts on X about $sprb, $amrn, generational, loaded the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +475%
- X Month XXXXX -XX%
- X Months XXXXXX +511%
- X Year XXXXXX +341%
Mentions: XX #
- X Months XX +491%
- X Year XX +756%
Followers: XXX #
- X Week XXX +7.10%
- X Month XXX +12%
- X Months XXX +69%
- X Year XXX +123%
CreatorRank: undefined #
Social Influence
Social topic influence $sprb #10, $amrn, generational, loaded, has been, at least, if you, ultra
Top accounts mentioned or mentioned by @grok @martinshkreli @monacobiotech @thothcapital @anthonystaj @seedy19tron @commonsenseplay @elonmusk @bryanjohnson @jfais20 @ryansttrader @adrianhorning @andreagtc @pharmdca @jasona @emuconspiracy @logicalthesis @hackertrader @brainymarsupial @tatethetalisman
Top Social Posts
Top posts by engagements in the last XX hours
"@drsprs @SSampson60391 $sprb and $amrn to break even In 12-18 months depending on position size. Only a psych NP but I've done as much DD as a generalist can do. I can't find another risk reward ratio (specifically spruce) to get even on"
X Link 2025-12-04T00:05Z XXX followers, XXX engagements
"@ThothCapital Iucky. I held like an idiot. Would have loaded the boat at under XX. Fundamentals are still intact and I don't see why FDA would not fast track this. Data is clear and not questionable. Generational miss on my part $SPRB"
X Link 2025-12-01T21:39Z XXX followers, XXX engagements
"@MartinShkreli are you going to hold through or cover hoping $sprb makes this back. hoping you can shed more light on that over time. ive done my own DD and heard yours but any more insight is always helpful"
X Link 2025-12-03T15:50Z XXX followers, 8260 engagements
"@BayStreetBull @anthonystaj $sprb it is"
X Link 2025-12-03T23:53Z XXX followers, XX engagements
"@anthonystaj $sprb it is"
X Link 2025-12-03T23:53Z XXX followers, XXX engagements
"@AgonInvestments @anthonystaj $sprb it is"
X Link 2025-12-03T23:54Z XXX followers, XX engagements
"@jeremyj0916 @Biotenic Same. $sprb and $amrn (way more weight on spruce) are the only relatively safe plays I know of to go heavier in order to break even or if you're savage turn a profit dependent on your position size"
X Link 2025-12-04T00:02Z XXX followers, XX engagements
"@FSUspencer @jeremyj0916 @MartinShkreli Take the extra cash and get into $sprb or imo $amrn. Going to take 12-18 months but better risk reward. Avxl crowd is interesting. I think they keep buying until they can't"
X Link 2025-12-04T00:19Z XXX followers, XXX engagements
"@houndcl @davidmiedz I never ever short for this reason but I felt compelled and got absolutely smoked. RR is hardly ever there but the pathology/biology made no sense. Still think something is funny but $sprb & $amrn for the win in 12-18 months. Long and gone"
X Link 2025-12-04T00:58Z XXX followers, XXX engagements
"@commonsenseplay @ShashiVas Why do you think $sprb has higher risk The data is irrefutable (to my understanding) and ICV method has been proven once in the real world already. FDA agreed to the biomarker and it was reduced. Study over X years. Genuine question. Thoughts"
X Link 2025-12-04T15:17Z XXX followers, XXX engagements
"@Relic57647069 @commonsenseplay My thoughts exactly. $sprb im trying to find downsides and I can't. FDA agreed to the biomarker and it was reduced dramatically. No one is arguing the data. Icv is used today. Regulatory risk which I don't see why on this one shouldn't be an issue"
X Link 2025-12-04T15:19Z XXX followers, XXX engagements
"@Anders_Research @idalopirdine @MartinShkreli $sprb to make it back. Why wouldn't FDA approve on phase X I can't find any bear thesis or information to prove otherwise. This looks like a lock"
X Link 2025-12-04T20:21Z XXX followers, XXX engagements
"@jacobg0121 XXX% correct.6070 % of CRLs for gene therapies and enzyme replacement therapies contain at least one CMC item. This is under LIC from biomarin. They have already executed this model so $sprb will just copy that.March package included CMC. Btd allows for rolling reviews. Low risk"
X Link 2025-12-05T04:51Z XXX followers, XXX engagements
"@Ricardomatepin @BrainyMarsupial I've done heavy DD on the data (my strength) and I don't see a reason why this wouldn't be acceptable in this context. Thoughts Also thanks for this back and forth CMC is my weak point so I appreciate the conversation here $sprb"
X Link 2025-12-05T05:01Z XXX followers, XXX engagements
"@seedy19tron I implore you to deep dive on $sprb esp at these levels. Open to chat if you would like"
X Link 2025-12-05T21:21Z XXX followers, XXX engagements
"@BrainyMarsupial @EmuConspiracy @Andre_AGTC Yeah in ultra rare the number shoots into the 80s. Fdas agreeance to take HS as a marker plus cortical endpoints at p0.0001 are irrefutable. They even met the more subjective endpoints hence the BTD. Real risk is CMC. We need to talk to a manf expert with exp in enzymes"
X Link 2025-12-06T15:07Z XXX followers, XX engagements
"@LogicalThesis @marketplunger1 $sprb triples"
X Link 2025-12-06T15:26Z XXX followers, XXX engagements
"@willkyi @drsprs Sizing is everything I way over sized this. Everyone needs to check out $sprb to make it back. RR is on our side this time on the long side"
X Link 2025-12-06T22:36Z XXX followers, XXX engagements
"@Respekchemistry @johnkmason @grok what's the price of chiesi's new ERT drug"
X Link 2025-12-07T19:31Z XXX followers, XX engagements